CH311609A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).Info
- Publication number
- CH311609A CH311609A CH311609DA CH311609A CH 311609 A CH311609 A CH 311609A CH 311609D A CH311609D A CH 311609DA CH 311609 A CH311609 A CH 311609A
- Authority
- CH
- Switzerland
- Prior art keywords
- anilide
- methyl
- propylamine
- chloro
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure (2-balogen-6-methyl-anilids).
Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basiseli substituierten Fettsäure- (2-halogen-6- methyl-anilids), welches dadurch gekennzeichnet ist, dass man eine Verbindung der Formel
EMI1.1
in weleher X einen reaktionsfahigen, während der Reaktion sich abspaltenden Rest bedeutet, mit n-Propylamin umsetzt.
Der Rest X kann in einem Halogenatom oder einem sonstigen f r den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsulfonyloxy-oder Arylsulfonyloxygruppe, beste- hen. Der Austausch der Gruppe X gegen den n-Propylaminrest erfolgt z. B. durch einfaches Erwärmen mit n-Propylamin gegebenenfalls in Gegenwart eines basisch reagierenden Kon densationsmittels oder von n-Propylamin im ¯berschu¯. Das n-Propylaminoacet- (2-chlor-6- methyl-anilid) ist ein farbloses, unter 0, 02 mm Hg bei 147-150 siedendes il. Das Hydroehlorid der Base schmilzt bei 253-257 .
Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden.
Beispiel :
40 Gewichtsteile Chloracet-(2-chlor-6-me thyl-anilid) (gewonnen durch Umsetzen von 2-Chlor-6-methyl-anilin mit Chloracetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 90 Gewichtsteilen ¯thanol , suspendiert und mit 50 Gewiehtsteilen n-Pro pylamin versetzt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Rea. ktionsgemisehes geht in Losung. Nun wird wä. hrend 4 Stunden bei Zimmertemperatur gerührt und dann einige Stunden bei 65-75 . Eine Probe mit Wasser und nachfolgend mit verdünnter Salzsäure versetzt ergibt wieder Lösung des ausgefallenen Niederschlages.
Mit Wasserda. mpf wird hierauf der Alkohol und das über- schüssige n-Propyla. min abgeblasen und nach dem Erkalten das zurückbleibende (il in Äther aufgenommen. Nach dem Trocknen der ätheri- schen Losung und Verjagen des Losungsmit- tels verbleibt ein 61, das durch Vakuum- destillation gereinigt wird. Man erhält 40 Gewichtsteile reines n-Propyl-aminoacet-(2-chlor6-methyl-anilid). Die Umsetzung mit n-Propylamin kann auch in Benzol stattfinden.
PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basiseh substituierten Fettsäure-(2-halogen6- methyl-anilids), dadurch gekennzeichnet, dass man eine Verbindung der Formel
**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.
Process for the production of a new basic substituted fatty acid (2-balogen-6-methyl-anilide).
The subject of the present patent is a process for the preparation of a new basiseli substituted fatty acid (2-halogen-6-methyl-anilide), which is characterized in that a compound of the formula
EMI1.1
in which X is a reactive radical which is split off during the reaction and reacts with n-propylamine.
The radical X can be in a halogen atom or another reactive substituent suitable for replacement with the basic radical, such as e.g. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the n-propylamine radical takes place, for. B. by simply heating with n-propylamine, optionally in the presence of a basic reacting condensation agent or n-propylamine in excess. The n-propylaminoacet- (2-chloro-6-methyl-anilide) is a colorless, below 0.02 mm Hg at 147-150 boiling. The hydrochloride of the base melts at 253-257.
The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives.
Example:
40 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are dissolved in 90 parts by weight of ethanol, suspended and mixed with 50 parts by weight of n-propylamine. The temperature rises slightly and a large part of the rea. ctionsgemisehes goes into solution. Now wä. Stirred for 4 hours at room temperature and then for a few hours at 65-75. A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate.
With Wasserda. The alcohol and the excess n-propyla then become mpf. min.blown off and after cooling the remaining (il taken up in ether. After drying the ethereal solution and driving off the solvent, a 61 remains, which is purified by vacuum distillation. 40 parts by weight of pure n-propyl-aminoacetate are obtained - (2-chloro-6-methyl-anilide) The reaction with n-propylamine can also take place in benzene.
PATENT CLAIM:
Process for the preparation of a new baseeh-substituted fatty acid (2-halogen6-methyl-anilide), characterized in that a compound of the formula
** WARNING ** End of DESC field could overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH311609T | 1952-02-25 | ||
CH307799T | 1952-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH311609A true CH311609A (en) | 1955-11-30 |
Family
ID=25735342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH311609D CH311609A (en) | 1952-02-25 | 1952-02-25 | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH311609A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
-
1952
- 1952-02-25 CH CH311609D patent/CH311609A/en unknown
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11512058B2 (en) | 2019-03-11 | 2022-11-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11643404B2 (en) | 2019-03-11 | 2023-05-09 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11603355B2 (en) | 2019-03-11 | 2023-03-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11696912B2 (en) | 2019-11-06 | 2023-07-11 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH311609A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311606A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311613A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311610A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311608A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311607A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311614A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311612A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311615A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311611A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311629A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311604A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311603A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311630A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311605A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311619A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311616A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311642A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311621A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311632A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311631A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311639A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311620A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311644A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH312572A (en) | Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide |